This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
<a target=_blank class=ftalternatingbarlinklarge href="http://www.patient.co.uk/showdoc/40002357
">http://www.patient.co.uk/showdoc/40002357
</a>
Check out this spirometry calculator. Its in metric for your height, but otherwise it seems ok. Hope this helps
<a target=_blank class=ftalternatingbarlinklarge href="http://www.patient.co.uk/showdoc/40002357
">http://www.patient.co.uk/showdoc/40002357
</a>
Check out this spirometry calculator. Its in metric for your height, but otherwise it seems ok. Hope this helps
<a target=_blank class=ftalternatingbarlinklarge href="http://www.patient.co.uk/showdoc/40002357
">http://www.patient.co.uk/showdoc/40002357
</a>
Check out this spirometry calculator. Its in metric for your height, but otherwise it seems ok. Hope this helps
<a target=_blank class=ftalternatingbarlinklarge href="http://www.patient.co.uk/showdoc/40002357
">http://www.patient.co.uk/showdoc/40002357
</a>
Check out this spirometry calculator. Its in metric for your height, but otherwise it seems ok. Hope this helps
<a target=_blank class=ftalternatingbarlinklarge href="http://www.patient.co.uk/showdoc/40002357
">http://www.patient.co.uk/showdoc/40002357
</a><br />
<br />Check out this spirometry calculator. Its in metric for your height, but otherwise it seems ok. Hope this helps
1. Meds are coming to the market that have efficacy in certain FEV1% ranges. Example: denufosol has been shown to work only in patients with FEV1 >75%.
2. Existing meds on the market may have efficacy in different doses for certain FEV1% ranges. Example: Pulmozyme in patients with FEV1 > 85%
3. From my understanding (someone can correct me if I'm wrong), at a certain FEV1% range you are eligible for tx in certain tx clinics.
4. Certain clinical studies (which Dr. Beall says is one of the most important things for CFers to participate in in the coming years to ensure the meds we've been fundraising to develop will come to the market in a timely manner) will only admit patients within a certain FEV1% range.
So FEV1 % is far from irrelevant and I commend you for wanting to understand what your % is. It's very useful to know above and beyond the liter value.
1. Meds are coming to the market that have efficacy in certain FEV1% ranges. Example: denufosol has been shown to work only in patients with FEV1 >75%.
2. Existing meds on the market may have efficacy in different doses for certain FEV1% ranges. Example: Pulmozyme in patients with FEV1 > 85%
3. From my understanding (someone can correct me if I'm wrong), at a certain FEV1% range you are eligible for tx in certain tx clinics.
4. Certain clinical studies (which Dr. Beall says is one of the most important things for CFers to participate in in the coming years to ensure the meds we've been fundraising to develop will come to the market in a timely manner) will only admit patients within a certain FEV1% range.
So FEV1 % is far from irrelevant and I commend you for wanting to understand what your % is. It's very useful to know above and beyond the liter value.
1. Meds are coming to the market that have efficacy in certain FEV1% ranges. Example: denufosol has been shown to work only in patients with FEV1 >75%.
2. Existing meds on the market may have efficacy in different doses for certain FEV1% ranges. Example: Pulmozyme in patients with FEV1 > 85%
3. From my understanding (someone can correct me if I'm wrong), at a certain FEV1% range you are eligible for tx in certain tx clinics.
4. Certain clinical studies (which Dr. Beall says is one of the most important things for CFers to participate in in the coming years to ensure the meds we've been fundraising to develop will come to the market in a timely manner) will only admit patients within a certain FEV1% range.
So FEV1 % is far from irrelevant and I commend you for wanting to understand what your % is. It's very useful to know above and beyond the liter value.
1. Meds are coming to the market that have efficacy in certain FEV1% ranges. Example: denufosol has been shown to work only in patients with FEV1 >75%.
2. Existing meds on the market may have efficacy in different doses for certain FEV1% ranges. Example: Pulmozyme in patients with FEV1 > 85%
3. From my understanding (someone can correct me if I'm wrong), at a certain FEV1% range you are eligible for tx in certain tx clinics.
4. Certain clinical studies (which Dr. Beall says is one of the most important things for CFers to participate in in the coming years to ensure the meds we've been fundraising to develop will come to the market in a timely manner) will only admit patients within a certain FEV1% range.
So FEV1 % is far from irrelevant and I commend you for wanting to understand what your % is. It's very useful to know above and beyond the liter value.
Here's why it's important to know your %ages:
<br />
<br />
<br />1. Meds are coming to the market that have efficacy in certain FEV1% ranges. Example: denufosol has been shown to work only in patients with FEV1 >75%.
<br />
<br />2. Existing meds on the market may have efficacy in different doses for certain FEV1% ranges. Example: Pulmozyme in patients with FEV1 > 85%
<br />
<br />3. From my understanding (someone can correct me if I'm wrong), at a certain FEV1% range you are eligible for tx in certain tx clinics.
<br />
<br />4. Certain clinical studies (which Dr. Beall says is one of the most important things for CFers to participate in in the coming years to ensure the meds we've been fundraising to develop will come to the market in a timely manner) will only admit patients within a certain FEV1% range.
<br />
<br />
<br />
<br />So FEV1 % is far from irrelevant and I commend you for wanting to understand what your % is. It's very useful to know above and beyond the liter value.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.